| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
52,135 |
46,933 |
$14.95M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
7,129 |
6,689 |
$2.48M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
6,057 |
5,820 |
$1.25M |
| G0378 |
Hospital observation service, per hour |
3,892 |
2,448 |
$986K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
4,232 |
4,085 |
$852K |
| 0450 |
Emergency room services |
10,811 |
9,937 |
$561K |
| 70450 |
Computed tomography, head or brain; without contrast material |
6,002 |
5,764 |
$373K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
3,348 |
3,225 |
$314K |
| 71045 |
Radiologic examination, chest; single view |
10,387 |
9,707 |
$288K |
| 99499 |
|
1,853 |
1,690 |
$234K |
| 71046 |
Radiologic examination, chest; 2 views |
6,216 |
5,971 |
$218K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
12,366 |
11,989 |
$174K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
2,816 |
2,693 |
$152K |
| 80051 |
|
42,797 |
35,241 |
$151K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
2,424 |
2,313 |
$151K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,003 |
989 |
$141K |
| 86885 |
|
2,752 |
2,537 |
$118K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
860 |
842 |
$112K |
| 76830 |
Ultrasound, transvaginal |
1,777 |
1,698 |
$110K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
41,500 |
35,159 |
$102K |
| 86900 |
|
4,482 |
4,063 |
$92K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
6,169 |
5,933 |
$77K |
| Z7502 |
|
2,368 |
2,300 |
$76K |
| 76801 |
|
1,337 |
1,153 |
$75K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
9,341 |
8,557 |
$70K |
| 82565 |
|
45,788 |
37,732 |
$69K |
| 84702 |
|
12,512 |
11,279 |
$64K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
392 |
381 |
$58K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
187 |
185 |
$57K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
825 |
825 |
$55K |
| 87088 |
|
9,593 |
9,212 |
$54K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
437 |
435 |
$53K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
688 |
685 |
$52K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
377 |
372 |
$49K |
| 84460 |
|
27,462 |
24,397 |
$49K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,541 |
2,349 |
$48K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,543 |
2,351 |
$48K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
2,335 |
2,310 |
$42K |
| 82247 |
|
24,896 |
21,899 |
$40K |
| 84520 |
|
38,779 |
32,409 |
$40K |
| 82947 |
|
35,023 |
31,279 |
$39K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
5,997 |
5,554 |
$37K |
| 84484 |
|
17,385 |
12,331 |
$36K |
| 84075 |
|
23,291 |
20,922 |
$36K |
| 84450 |
|
21,833 |
19,842 |
$36K |
| 74174 |
|
163 |
162 |
$36K |
| 83880 |
|
6,813 |
6,417 |
$36K |
| 73630 |
|
1,117 |
1,056 |
$35K |
| 73562 |
|
993 |
920 |
$34K |
| 83690 |
|
16,254 |
15,194 |
$34K |
| 93971 |
|
759 |
722 |
$34K |
| 71250 |
|
426 |
425 |
$32K |
| 86901 |
|
4,480 |
4,062 |
$30K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,153 |
1,983 |
$29K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,827 |
3,609 |
$28K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
235 |
235 |
$26K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
2,462 |
2,298 |
$25K |
| 73610 |
|
829 |
780 |
$24K |
| 81003 |
|
25,917 |
24,344 |
$23K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,102 |
1,983 |
$23K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,993 |
2,865 |
$22K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
6,244 |
5,907 |
$21K |
| 74018 |
|
422 |
400 |
$21K |
| 73030 |
|
622 |
575 |
$20K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
15,884 |
13,168 |
$19K |
| 85027 |
|
8,273 |
7,032 |
$19K |
| 70496 |
|
111 |
109 |
$18K |
| 82248 |
|
10,545 |
10,020 |
$18K |
| 73130 |
|
656 |
590 |
$18K |
| 80061 |
Lipid panel |
2,487 |
2,397 |
$17K |
| 70498 |
|
107 |
105 |
$17K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,153 |
1,816 |
$16K |
| 90686 |
|
1,759 |
1,755 |
$16K |
| 83735 |
|
11,028 |
9,351 |
$16K |
| 0637 |
|
60,566 |
23,528 |
$16K |
| 82310 |
|
9,192 |
8,326 |
$13K |
| 87040 |
|
7,153 |
3,641 |
$13K |
| 87505 |
|
153 |
151 |
$13K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
811 |
763 |
$12K |
| 85610 |
|
10,518 |
8,594 |
$12K |
| 76770 |
|
181 |
179 |
$11K |
| 70486 |
|
92 |
92 |
$11K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
839 |
826 |
$11K |
| 72141 |
|
63 |
63 |
$11K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
697 |
670 |
$10K |
| 93970 |
|
173 |
170 |
$10K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
95 |
93 |
$9K |
| 73110 |
|
317 |
278 |
$9K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
60 |
55 |
$9K |
| 86141 |
|
2,497 |
2,334 |
$9K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,982 |
1,918 |
$9K |
| 82570 |
|
2,970 |
2,659 |
$9K |
| 86780 |
|
967 |
903 |
$8K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
710 |
647 |
$8K |
| 80076 |
|
1,467 |
1,400 |
$8K |
| 83605 |
|
4,159 |
3,214 |
$8K |
| 83970 |
|
474 |
448 |
$8K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
79 |
75 |
$7K |
| 82728 |
|
1,119 |
1,054 |
$7K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
7,728 |
5,896 |
$7K |
| 70491 |
|
39 |
39 |
$7K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,226 |
2,162 |
$7K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,062 |
1,044 |
$7K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
5,440 |
4,621 |
$6K |
| 86803 |
|
612 |
609 |
$6K |
| 76870 |
|
78 |
75 |
$6K |
| 76881 |
|
61 |
60 |
$6K |
| 85379 |
|
1,475 |
1,434 |
$6K |
| 84156 |
|
2,765 |
2,509 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
815 |
405 |
$5K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,232 |
1,088 |
$5K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
519 |
377 |
$5K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
8,788 |
7,884 |
$5K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
181 |
180 |
$5K |
| 80306 |
|
825 |
804 |
$5K |
| 73590 |
|
111 |
110 |
$5K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,345 |
2,990 |
$4K |
| 87340 |
|
996 |
908 |
$4K |
| 74022 |
|
162 |
155 |
$4K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
148 |
146 |
$4K |
| 0258 |
|
1,609 |
1,446 |
$4K |
| 83615 |
|
1,172 |
1,076 |
$4K |
| 84439 |
|
836 |
791 |
$4K |
| 85730 |
|
2,517 |
2,295 |
$4K |
| 0250 |
|
6,575 |
4,572 |
$4K |
| 83550 |
|
963 |
912 |
$4K |
| 84100 |
|
4,341 |
3,772 |
$4K |
| 76536 |
|
55 |
55 |
$4K |
| 82607 |
|
382 |
372 |
$3K |
| 72131 |
|
45 |
45 |
$3K |
| 87081 |
|
2,251 |
2,192 |
$3K |
| 87497 |
|
101 |
79 |
$3K |
| 90656 |
|
526 |
526 |
$3K |
| 82077 |
|
1,191 |
1,132 |
$3K |
| 83540 |
|
937 |
886 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,160 |
3,049 |
$3K |
| 85652 |
|
2,119 |
1,993 |
$3K |
| 82040 |
|
1,968 |
1,811 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
265 |
260 |
$2K |
| 81513 |
|
29 |
28 |
$2K |
| 82043 |
|
917 |
890 |
$2K |
| 82550 |
|
1,379 |
1,276 |
$2K |
| 84132 |
|
1,349 |
1,125 |
$2K |
| 86762 |
|
387 |
333 |
$2K |
| 76380 |
|
26 |
26 |
$2K |
| 87210 |
|
977 |
891 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
144 |
141 |
$2K |
| 87449 |
|
208 |
206 |
$2K |
| 73140 |
|
29 |
28 |
$2K |
| 90688 |
|
102 |
100 |
$2K |
| 82950 |
|
466 |
466 |
$2K |
| 82746 |
|
193 |
192 |
$2K |
| 86787 |
|
388 |
334 |
$2K |
| 80179 |
|
592 |
572 |
$1K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,959 |
1,833 |
$1K |
| 87481 |
|
44 |
43 |
$1K |
| 82962 |
|
1,631 |
1,020 |
$1K |
| 86765 |
|
123 |
123 |
$1K |
| 86923 |
|
17 |
13 |
$1K |
| 82105 |
|
115 |
111 |
$1K |
| 73090 |
|
51 |
49 |
$1K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
2,029 |
1,857 |
$1K |
| 73080 |
|
61 |
53 |
$1K |
| 83520 |
|
236 |
126 |
$1K |
| J3490 |
Unclassified drugs |
2,883 |
2,399 |
$1K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
29 |
28 |
$1K |
| 86364 |
|
105 |
105 |
$1K |
| 82805 |
|
61 |
54 |
$1K |
| 84550 |
|
451 |
421 |
$973.13 |
| 73502 |
|
42 |
40 |
$956.21 |
| 0710 |
|
314 |
311 |
$950.37 |
| 80197 |
|
88 |
77 |
$839.69 |
| 87186 |
|
768 |
750 |
$748.10 |
| J1815 |
Injection, insulin, per 5 units |
1,755 |
726 |
$733.48 |
| 86704 |
|
88 |
88 |
$624.99 |
| 86317 |
|
59 |
59 |
$616.00 |
| 81015 |
|
286 |
277 |
$584.62 |
| 96367 |
|
100 |
93 |
$510.04 |
| 84165 |
|
137 |
133 |
$502.00 |
| 87631 |
|
111 |
109 |
$494.87 |
| P9021 |
Red blood cells, each unit |
15 |
13 |
$466.01 |
| 83001 |
|
29 |
29 |
$465.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
761 |
497 |
$449.19 |
| 87205 |
|
273 |
220 |
$445.32 |
| 87324 |
|
57 |
56 |
$439.88 |
| G0008 |
Administration of influenza virus vaccine |
1,146 |
1,144 |
$432.89 |
| 84146 |
|
28 |
28 |
$425.00 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
305 |
249 |
$406.65 |
| 0370 |
|
313 |
310 |
$396.90 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
557 |
489 |
$383.43 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
829 |
827 |
$381.84 |
| 84403 |
|
25 |
25 |
$372.00 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
54 |
53 |
$354.24 |
| 90662 |
|
189 |
187 |
$338.49 |
| 72100 |
|
24 |
24 |
$333.60 |
| 97161 |
|
213 |
205 |
$315.11 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
687 |
397 |
$285.24 |
| Q0144 |
Azithromycin dihydrate, oral, capsules/powder, 1 gram |
43 |
42 |
$281.38 |
| 84153 |
|
39 |
39 |
$255.00 |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
23 |
12 |
$248.00 |
| 86140 |
|
65 |
56 |
$226.57 |
| 82951 |
|
14 |
14 |
$220.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
583 |
536 |
$212.37 |
| 86038 |
|
28 |
28 |
$210.00 |
| 84295 |
|
74 |
68 |
$202.72 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
366 |
225 |
$200.32 |
| 86308 |
|
104 |
103 |
$192.49 |
| J2060 |
Injection, lorazepam, 2 mg |
308 |
266 |
$191.54 |
| 82784 |
|
14 |
14 |
$189.34 |
| 83021 |
|
121 |
92 |
$187.09 |
| J1836 |
Injection, metronidazole, 10 mg |
125 |
82 |
$144.16 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
13 |
12 |
$112.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
512 |
423 |
$104.39 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
158 |
126 |
$101.82 |
| 83721 |
|
31 |
26 |
$99.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
13 |
13 |
$86.40 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
161 |
142 |
$81.94 |
| J3480 |
Injection, potassium chloride, per 2 meq |
378 |
274 |
$80.96 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
111 |
98 |
$71.30 |
| 80053 |
Comprehensive metabolic panel |
12 |
12 |
$70.10 |
| 82952 |
|
14 |
14 |
$70.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
592 |
280 |
$68.35 |
| 87807 |
|
55 |
54 |
$67.54 |
| J1940 |
Injection, furosemide, up to 20 mg |
535 |
294 |
$66.41 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
19 |
12 |
$66.10 |
| J0737 |
Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg |
14 |
12 |
$55.42 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
55 |
54 |
$46.67 |
| J0456 |
Injection, azithromycin, 500 mg |
266 |
190 |
$46.26 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
35 |
33 |
$45.45 |
| 84155 |
|
15 |
12 |
$35.00 |
| 87149 |
|
28 |
28 |
$32.48 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
49 |
36 |
$28.42 |
| C9113 |
Injection, pantoprazole sodium, per vial |
189 |
143 |
$25.39 |
| J7510 |
Prednisolone oral, per 5 mg |
117 |
115 |
$23.79 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
43 |
43 |
$20.68 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
163 |
153 |
$15.18 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
29 |
12 |
$7.70 |
| 85014 |
|
25 |
18 |
$1.72 |
| 84145 |
|
14 |
12 |
$0.00 |
| 92610 |
|
30 |
28 |
$0.00 |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
38 |
25 |
$0.00 |
| 90749 |
|
26 |
26 |
$0.00 |
| 99238 |
Hospital discharge day management, 30 minutes or less |
18 |
18 |
$0.00 |
| 3044F |
|
95 |
94 |
$0.00 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
15 |
13 |
$0.00 |